Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00794950
Title Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan
Indications

prostatic urethra urothelial carcinoma

non-invasive bladder urothelial carcinoma

Therapies

Sunitinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.